Abstract
Monoamine oxidase (MAO) action has been involved in the regulation of neurotransmitters levels, cell signaling, cellular growth, and differentiation as well as in the balance of the intracellular polyamine levels. Although so far obscure,MAOinhibitors are believed to have some effect on tumors progression. 1,4‐naphthoquinone (1,4‐NQ) has been pointed out as a potential pharmacophore for inhibition of bothMAOandDNAtopoisomerase activities, this latter associated with antitumor activity. Herein, we demonstrated that certain antitumor 1,4‐NQs, including spermidine‐1,4‐NQ, lapachol, andnor‐lapachol display inhibitory activity on humanMAO‐A andMAO‐B. Kinetic studies indicated that these compounds are reversible and competitiveMAOinhibitors, being the enzyme selectivity greatly affected by substitutions on 1,4‐NQring. Molecular docking studies suggested that the most potentMAOinhibitors are capable to bind to theMAOactive site in close proximity of flavin moiety. Furthermore, ability to inhibit bothMAO‐A andMAO‐B can be potentialized by the formation of hydrogen bonds between these compounds andFADand/or the residues in the active site. Although spermidine‐1,4‐NQs exhibit antitumor action primarily by inhibiting topoisomerase viaDNAintercalation, our findings suggest that their effect onMAOactivity should be taken into account when their application in cancer therapy is considered.

This publication has 34 references indexed in Scilit: